Blimp-1 and IRF4 can be activated by factors other than B cell receptor signalling, such as IL-21 and IL-6 [43] or IFNα and IL-6 [44], cytokines implicated in the pathogenesis of type 1 diabetes. Here, PRDM1 is linked to type 1 diabetes mellitus.